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Maintenance of hematopoietic progenitors ensures a continuous supply of blood cells during the lifespan
of an organism. Thus, understanding the molecular basis for progenitor maintenance is a continued focus
of investigation. A large pool of undifferentiated blood progenitors are maintained in the Drosophila
hematopoietic organ, the larval lymph gland, by a complex network of signaling pathways that are
mediated by niche-, progenitor-, or differentiated hemocyte-derived signals. In this study we examined
the function of the Drosophila ﬁbroblast growth factor receptor (FGFR), Heartless, a critical regulator of
early lymph gland progenitor speciﬁcation in the late embryo, during larval lymph gland hematopoiesis.
Activation of Heartless signaling in hemocyte progenitors by its two ligands, Pyramus and Thisbe, is both
required and sufﬁcient to induce progenitor differentiation and formation of the plasmatocyte-rich
lymph gland cortical zone. We identify two transcriptional regulators that function downstream of
Heartless signaling in lymph gland progenitors, the ETS protein, Pointed, and the Friend-of-GATA (FOG)
protein, U-shaped, which are required for this Heartless-induced differentiation response. Furthermore,
cross-talk of Heartless and target of rapamycin signaling in hemocyte progenitors is required for
lamellocyte differentiation downstream of Thisbe-mediated Heartless activation. Finally, we identify the
Drosophila heparan sulfate proteoglycan, Trol, as a critical negative regulator of Heartless ligand signaling
in the lymph gland, demonstrating that sequestration of differentiation signals by the extracellular
matrix is a unique mechanism employed in blood progenitor maintenance that is of potential relevance
to many other stem cell niches.
& 2013 Published by Elsevier Inc.Introduction
The maintenance of hematopoietic stem cells is a crucial
process for the normal production of blood cells, but in addition,
understanding its molecular basis could enhance the therapeutic
beneﬁts of this cell population. Studies of hematopoiesis and the
regulation of hematopoietic progenitors have identiﬁed a variety
of molecular mechanisms that regulate progenitor/stem cell main-
tenance (Arai and Suda, 2007; Seita and Weissman, 2010; Teitell
and Mikkola, 2006). As in vertebrate systems, Drosophila hemato-
poiesis requires a population of multipotent progenitor cells that
give rise to all differentiated hemocyte lineages (Mandal et al.,
2007). Previous studies of Drosophila larval hematopoiesis
have uncovered a complex network of signaling pathways thatlsevier Inc.
uth, Gonda 4554B,
5446.
(J. Martinez-Agosto).cooperate to regulate hemocyte progenitor maintenance. These
include niche-derived Hedgehog signaling (Krzemien et al., 2007;
Mandal et al., 2007), an adenosine deaminase growth factor
A-mediated signal emanating from differentiated hemocytes
(Mondal et al., 2011), and Wingless signaling, which autonomously
regulates progenitor cell maintenance (Sinenko et al., 2009). In
contrast, the signal(s) required for differentiation of Drosophila
hemocyte progenitors during larval development remain largely
unknown.
One wave of hematopoiesis in Drosophila occurs in the larval
lymph gland (Lebestky et al., 2000; Tepass et al., 1994). Studies of
the lymph gland have allowed genetic dissection of signaling
networks that operate in a niche-, progenitor- or differentiated
hemocyte-dependent manner to maintain blood homeostasis,
owing to the ability to perform cell-type speciﬁc genetic manip-
ulation with direct in vivo imaging of its effects on these distinct
cell populations. In the lymph gland, multipotent blood progeni-
tors termed prohemocytes express high levels of Drosophila (d)E-
cadherin, or Shotgun, and are compactly arranged in a medial
Fig. 1. Expression patterns of Heartless and its ligands, Thisbe and Pyramus, in the lymph gland. All panels represent wild-type lymph glands. In panels B–B”’ dome-Gal4 is used
to drive UAS-2xEGFP (green) expression in MZ prohemocytes. In panels C–C”’ HHLT (hand-gal4, hml-gal4, UAS-2xEGFP, UAS-FLP; A5C-FRT-STOP-FRT-gal4) is used to clonally
express UAS-2xEGFP (green) in lymph gland hemocytes. In panels F–J” thisbe-Gal4 drives UAS-2xEGFP (green) expression in thisbe-expressing hemocytes. Peroxidasin (Pxn)
expression is shown in red in panels B”–B”’ and I’–I”. Antennapedia (Antp) expression is shown in red in panels C”–C”’ and J–J”. Heartless (Htl) expression is shown in blue in
panels B–C”’ and in red in panels F–F”. The MZ marker, Shotgun (Shg), is shown in red in panels G–G”. Thisbe transcript expression is shown in red in panel D, and pyramus
transcript expression is shown in red in panel E. (A) Schematic diagram of a wandering third instar lymph gland primary and secondary lobe. Differentiated plasmatocytes
(red) and crystal cells (blue) localize to the peripheral cortical zone (CZ). Prohemocytes (green) are compactly arranged in the Medullary Zone (MZ). Posterior signaling
center (PSC) cells (gray) localize to the posterior tip of the primary lobe. Secondary lobes mostly consist of undifferentiated progenitors (green) with few differentiated
hemocytes (red). Pericardial cells (PC) intercalate between the primary and secondary lobes. DV, dorsal vessel. (B–B”’) Heartless (Htl, blue) is strongly expressed in dome+
hemocyte progenitors of the MZ (green), and is largely reduced in Pxn+ (red) differentiated hemocytes of the peripheral CZ. (C–C”’) Heartless (blue) is detected in Antp+ cells
of the PSC (red) at lower levels than adjacent hemocytes of the lymph gland. (D–E) Fluorescence in situ hybridization against thisbe (D) or pyramus (E) mRNA transcripts
demonstrates highest expression in MZ hemocytes. (F–F”) Thisbe (green) expression overlaps (yellow) with Heartless (red) expression in medial lymph gland regions,
although not all Heartless+ cells are thisbe+. Thisbe4GFP is strongly expressed in a subset of MZ cells. (G–H”) Thisbe (green) expression overlaps (yellow) with Shotgun (Shg,
red) in the MZ, conﬁrming highest thisbe expression in MZ prohemocytes and reduced or negative thisbe expression in Shotgun-negative hemocytes of the peripheral CZ.
(I–I”) High thisbe (green) expression rarely overlaps (yellow) with high Pxn expression, although thisbe expression often extends to the most medial Pxn+ hemocytes of the
CZ. Co-expression of low levels of thisbe and low levels of Pxn are also observed in some scattered hemocytes. (J–J”) Most, but not all, Antp+ PSC cells express thisbe (green,
overlap in yellow). Scale bars¼50 mm. Scale bar in A corresponds to A–B”’; scale bar in I corresponds to I–J.
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Fig. 1A) (Jung et al., 2005). These prohemocytes give rise to all
mature, myeloid-like hemocyte lineages (Jung et al., 2005):
macrophage-like plasmatocytes, platelet-like crystal cells, and
lamellocytes, which are not normally present in a healthy larva
but are induced to differentiate upon parasitic wasp infection
(Lanot et al., 2001; Sorrentino et al., 2002). Differentiated hemo-
cytes that arise from lymph gland prohemocytes populate the
peripheral cortical zone (CZ; Fig. 1A) (Jung et al., 2005) and do not
enter circulation until the onset of metamorphosis (Grigorian
et al., 2011b). Finally, the posterior signaling center (PSC;
Fig. 1A), a small group of cells at the posterior tip of each primary
lobe, functions as a hematopoietic niche by supplying pro-
maintenance signals, such as Hedgehog, to progenitors (Krzemien
et al., 2007; Lebestky et al., 2003; Mandal et al., 2007). The strict
dependence of Drosophila progenitor maintenance on the PSC
(Krzemien et al., 2007; Mandal et al., 2007) highlights the unique
role within the lymph gland of a hematopoietic niche devoted to
the maintenance of myeloid lineage-restricted progenitors.
Similar to the vertebrate aorta-gonadal mesonephros (AGM),
wherein hematopoietic and vascular lineages are derived from a
common progenitor cell called the hemangioblast (Ema et al.,
2003; Medvinsky and Dzierzak, 1996), a common origin of
Drosophila vascular cells and hematopoietic lymph gland progeni-
tors has been described (Mandal et al., 2004). Speciﬁcally, the
Drosophila lymph gland, vascular cardioblasts (heart and aorta),
and pericardial nephrocytes all arise from the cardiogenic meso-
derm late in embryonic development. Clonal analysis demon-
strated that a single cardiogenic mesoderm cell can give rise to
both lymph gland and vascular cells, providing evidence for a
Drosophila hemangioblast, akin to the vertebrate AGM (Mandal
et al., 2004). Amongst the signaling pathways required for devel-
opment of all three lineages derived from the cardiogenic meso-
derm is the ﬁbroblast growth factor receptor (FGFR) homolog,
Heartless (Htl) (Beiman et al., 1996; Frasch, 1995; Mandal et al.,
2004). Loss-of-function mutations in Heartless result in the
absence of a heart/cardioblasts (Shishido et al., 1997), and impair
lymph gland progenitor development (Mandal et al., 2004). In
contrast, constitutive activation of Heartless in the cardiogenic
mesoderm increases the number of blood progenitors, nephro-
cytes, and cardioblasts (Grigorian et al., 2011a).
Heartless is one of only two Drosophila FGFRs and is activated
by two FGF-8-like ligands, Pyramus (Pyr) and Thisbe (Ths) (Gryzik
and Müller, 2004; Stathopoulos et al., 2004). Heartless signaling
has been studied extensively in the context of mesoderm devel-
opment, migration during gastrulation, and differentiation of
mesodermal lineages (Beiman et al., 1996; Gisselbrecht et al.,
1996; Klingseisen et al., 2009; McMahon et al., 2010). It has also
been shown to play a major role in glial cell migration and
differentiation in the eye (Franzdottir et al., 2009). The second
Drosophila FGFR, Breathless, is activated by a single FGF ligand,
branchless, and is critical for morphogenesis of the trachea during
embryonic, larval and pupal developmental stages (reviewed in
Cabernard et al., 2004). With only three potential FGF-FGFR
combinations, Drosophila FGFR signaling is less complex than in
vertebrates, wherein 22 FGF ligands and four FGFRs contribute to
over 120 potential FGF-FGFR interactions (Zhang et al., 2006).
Despite this apparent simplicity, recent studies have provided
evidence for overlapping functions of Pyramus and Thisbe, in
which they act redundantly to provide robust signaling, as well as
distinct functions due to their differential effects on Heartless
activation (Franzdottir et al., 2009; Kadam et al., 2009; Klingseisen
et al., 2009).
Despite the functional requirement of Heartless signaling dur-
ing development of early lymph gland progenitors in the late
embryo, a role for Heartless signaling in the larval lymph gland iscurrently unknown. Here, we provide evidence that activation of
Heartless signaling by both of its ligands, Thisbe and Pyramus, is
both required and sufﬁcient for differentiation of hemocyte
progenitors in the lymph gland. We demonstrate that these effects
are Ras-mediated, and dependent on two downstream transcrip-
tional effectors, Pointed and U-Shaped, as well as on cross-talk
with the target of rapamycin (TOR) growth signaling pathway.
Finally, we identify the Drosophila heparan sulfate proteoglycan,
Trol, as a crucial modulator of Heartless signaling in the lymph
gland, demonstrating that sequestration of differentiation signals
by the extracellular matrix is a unique mechanism utilized to
maintain blood progenitors, in addition to niche-, progenitor-, and
differentiated hemocyte-generated maintenance signals.Materials and methods
Drosophila stocks and crosses
All RNAi lines used in the described experiments were obtained
from the Vienna Drosophila RNAi Center (VDRC, Vienna, Austria).
The following Drosophila stocks were used: UAS-heartlessDN, UAS-
[d4EBP(LL)], and thisbe-Gal4 (Bloomington); UAS-heartlessAct
(A. Michelson); UAS-thisbeWT and UAS-pyramusWT (A. Stathopou-
los); FRT82B heartlessAB42 and FRT42B pyramusEx36 (unpublished
reagents; kindly provided by A. Stathopoulos); UAS-rasDN, UAS-
ras85BAct, UAS-rolled(MAPK)Act, UAS-pointedP2Act, and Trol-GFP pro-
tein trap line ZCL1973X (V. Hartenstein); UAS-u-shapedWT (N.
Fossett); FRT82B ras85BΔC40B and FRT82B pointedΔ88 (J. Bateman);
UAS-vein, UAS-secreted-spitz, UAS-pvf1, and UAS-pvf2 (U. Banerjee);
UAS-secreted-gurken and UAS-secreted-keren (A. Simcox); UAS-jelly-
belly (J. Weiss); UAS-branchless (M. Krasnow); hh-F4f-GFP
(R. Schulz).
Hemocyte progenitor-speciﬁc gene expression was performed
using dome-gal4, UAS-2xEGFP (S. Noselli). Expression of UAS-
pyramusWT, UAS-u-shapedWT or UAS-pointedRNAi genetic constructs
in hemocyte progenitors was performed using dome-gal4; P{tubP-
gal80[ts20]} (U. Banerjee) to permit larval viability; larvae were
shifted from the permissive temperature (18 1C) to the restrictive
temperature (29 1C) at the onset of the second instar stage.
Clonal analysis
FLP-out clones in the lymph gland were generated using HHLT
(hand-gal4, hml-gal4, UAS-2xEGFP, UAS-FLP; A5C-FRT-STOP-FRT-
gal4) as described (Evans et al., 2009). Genotypes for MARCM
FRT clones (Mosaic Analysis with a Repressible Cell Marker) (Lee
and Luo, 1999) are as follows: hs-ﬂp FRT82B heartlessAB42 FRT82B
Tub-mCD8-GFP; hs-ﬂp FRT82B pointedΔ88 FRT82B Tub-mCD8-GFP;
and hs-ﬂp FRT82B rasΔC40B FRT82B Tub-mCD8-GFP. Genotypes for
FLP-FRT clones are as follows: FRT42B pyramusEx36 FRT42B UbiGFP;
hs-ﬂp. Clones were induced by a 2-hour heat shock at 37 1C in late
embryos or early ﬁrst instar larvae.
Larval staging
Staging was performed at 25 1C and the following time-points
after egg hatching (AEH) were used for larval stages: 54 h AEH
(second instar, L2), 72 h AEH (early third instar, eL3), 116 h AEH
(wandering third instar, wL3).
Immunohistochemistry
Primary antibodies used: mouse anti-Peroxidasin (Pxn, 1:300;
J. Fessler), rabbit anti-prophenoloxidase (PPO, 1:300; M. Kanost),
mouse anti-P1 and anti-L1 (1:20; I. Ando), rabbit anti-p4EBP
(1:300; Cell Signaling), rat anti-Heartless and anti-PVR (1:400,
B. Shilo), rat anti-Shotgun (1:400, V. Hartenstein), rat anti-Sprouty
(1:400, M. Krasnow), and mouse anti-Antp (1:20, DSHB). Lymph
Fig. 2. Heartless and its ligands regulate progenitor differentiation in the lymph gland. All panels represent wandering third instar. In all panels, dome-Gal4, UAS-2xEGFP (wild-
type, A–A”, H) is used to express UAS-heartlessDN (B–B”), UAS-thisbeRNAi (C–C”), UAS-pyramusRNAi (D–D”), UAS-heartlessAct (E–E”), UAS-thisbeWT (F–F”, I), and UAS-pyramusWT
(G–G”, J), in prohemocytes (green). Differentiation markers are labeled to the left of corresponding rows. (A–A”) Wild-type lymph gland primary lobe. Peroxidasin (Pxn, red,
A) is expressed in differentiated hemocytes (dome–) as well as in a small population of dome+/Pxn+ intermediate progenitors at the MZ/CZ boundary. P1 (red, A’) and
prophenoloxidase (PPO, blue, A’) label terminally differentiated plasmatocytes and crystal cells, respectively. L1 (red, A”) marks lamellocytes, not present in wild-type. (B–D”)
Overexpression of heartlessDN (B) or downregulation of thisbe (C) or pyramus (D) in prohemocytes impairs CZ formation. Plasmatocytes and crystal cells are restricted to a
thin peripheral layer compared to wild-type (compare B’, C’, and D’ to A’). Reduced Heartless function in prohemocytes induces rare lamellocytes in the lymph gland (42% of
lymph glands, n¼150, B”), but thisbe downregulation does not (C”), while pyramus downregulation induces many lamellocytes to differentiate in the lymph gland (78% of
lymph glands, n¼64, D”). (E–G”) Overexpression of heartlessAct (E), thisbeWT (F), or pyramusWT (G) is sufﬁcient to induce almost the complete loss of dome+/Pxn– prohemocytes
due to premature differentiation into plasmatocytes and crystal cells (E’, F’, and G’). While robust lamellocyte differentiation occurs upon heartlessAct (82% of lymph glands,
n¼60, E”) or thisbeWT (88% of lymph glands, n¼42, F”) overexpression in prohemocytes, lamellocytes are not observed upon pyramusWT overexpression (G”). (H) Wild-type
lymph gland secondary lobes. Lymph gland secondary lobes consist mostly of undifferentiated dome+/Pxn– hemocytes, although a few differentiating Pxn+ hemocytes are
observed at the periphery. (I–J) Overexpression of thisbeWT (I) or pyramusWT (J) in dome+ hemocytes is sufﬁcient to induce severe hypertrophy and differentiation of lymph
gland secondary lobes. (K) Quantiﬁcation of Pxn+ hemocyte population distribution (% area) in the lymph gland. Data are represented as mean7s.d., n¼10. Asterisks denote
statistically signiﬁcant results compared to wild-type (dome4), measured by Student’s t-test. List of abbreviations: Heartless (Htl), Thisbe (Ths), Pyramus (Pyr), Pointed (Pnt),
U-shaped (Ush). Scale bars¼50 mm. Scale bar in A corresponds to A- G” except for the following additional magniﬁcations: X0.8 for F and F’ and X0.7 for E” and F”. Scale bar in
H corresponds to H–J.
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for 20 min in 3.7% formaldehyde. Lymph glands were blocked in
10% NGS with 0.4% TritonX-100 in 1xPBS (PBST) for 1 h at room
temperature. Primary antibodies were diluted in PBST and incu-
bated with lymph glands in 96-well MicroWell plates (Thermo
Scientiﬁc) overnight at 4 1C in a humidiﬁed chamber. Lymph
glands were then washed 415 min in PBST with gentle shaking.
Secondary antibodies (Jackson Immunoresearch) were prepared in
10% NGS in 0.4%PBST at a concentration of 1:400 and incubated
with lymph glands overnight in a dark, humidiﬁed chamber
at 4 1C. Lymph glands were then washed 415 min in PBST with
gentle shaking and 115 min in 1 PBS. Lymph glands were
mounted using Vectashield (Vector Laboratories). Samples were
imaged using a Carl Zeiss LSM 310 Laser Scanning Confocal
Microscope.
In situ hybridization
Tissue dissection, in situ hybridization and signal ampliﬁca-
tion with ﬂuorescent-labeled antibodies were performed as in
Nagaraj et al. (2012). For the anti-pyramus probe, a 561-base-pair
DNA fragment from genomic DNA was ampliﬁed via PCR with
Pyramus forward (5’-CGATGCTGATATGCAACTGG-3’) and Pyramus
reverse primers (5’-TAATACGACTCACTATAGGCTGAGGCCACGAA
GAAGTTT-3’), which has the RNA polymerase T7 promoter
(sequence designed by Young Bae, A. Stathopoulos Lab). For
the anti-thisbe probe, a 559-base-pair DNA fragment from
genomic DNA was ampliﬁed via PCR with Thisbe forward
(5’-CTCCCAGCTGGTGATAGAGC-3’) and Thisbe reverse primers
(5’-TAATACGACTCACTATAGGATCGATGTCGATATCTCCGC-3’), which has
the RNA polymerase T7 promoter (sequence designed by Young Bae,
A. Stathopoulos Lab).
Rapamycin treatment
Crosses were set up on 15 mM rapamycin food plates and larvae
were grown at 25 1C until wandering third instar stage.
Quantiﬁcation of Pxn+ hemocyte population distribution (% area) in
the lymph gland
Methodology to determine the proportion of Pxn+ hemocytes
in the lymph gland was performed as in Dragojlovic-Munther and
Martinez-Agosto (2012). Statistical signiﬁcance of data was
assessed with Student’s t-test.Results
Heartless, Thisbe and Pyramus expression in the lymph gland
Although Heartless signaling is required to generate lymph
gland progenitors in the embryo, a role for Heartless signaling in
the larval lymph gland remains unknown. We reasoned that a role
for Heartless in hematopoiesis would extend to later stages of
lymph gland development, given its essential role in the embryo.
We therefore ﬁrst examined Heartless expression in the lymph
gland at distinct larval stages. Undifferentiated hemocyte progeni-
tors in the lymph gland are identiﬁed by positive expression of
the Janus tyrosine kinase/signal transducers and activators of
transcription (JAK/STAT) receptor domeless (dome), and negative
expression of the early differentiation marker, Peroxidasin (Pxn)
(dome+/Pxn–), a component of extracellular matrix (Nelson et al.,
1994). As progenitors begin to differentiate, they co-express
both dome and Pxn at low levels (dome+/Pxn+) and represent a
population of intermediate progenitors (Dragojlovic-Munther and
Martinez-Agosto, 2012; Krzemien et al., 2010). During the second
larval instar stage (L2) the lymph gland is largely undifferentiated,
but a small population of differentiating progenitors (dome+/Pxn+)begin to emerge at the lymph gland periphery (Fig. S1A). Heartless
expression is detected throughout the entire second instar lymph
gland (Fig. S1A’), and overlaps completely with the progenitor
marker, dome (Fig. S1A”). By early third instar stage (eL3), the
number of Pxn+ hemocytes expands, forming an early CZ (Fig.
S1B). Heartless expression is still detected throughout the lymph
gland (Fig. S1B’) but is most strongly expressed in dome+ progeni-
tors (Fig. S1B”). By the wandering third instar stage (wL3), at the
end of larval development, a mature CZ is observed at the lymph
gland periphery (Fig. S1C). Heartless expression is still detected at
high levels throughout the population of dome+ progenitors but is
absent in a subset of dome –/Pxn+ hemocytes in the peripheral CZ
(white arrows, Fig. S1C–C”and 1B–B”’). In addition to high Heartless
expression in dome+ MZ prohemocytes (Fig. 1B–B”’), Heartless
expression is also detected in Antennapedia+ (Antp+) cells of the
posterior signaling center (PSC) (Fig. 1C–C”’).
Unlike the homogenous expression of Heartless during the
second and early third instar stages, expression of its ligand thisbe
is more restricted in the lymph gland, and is not found in all
Heartless+ hemocytes (Fig. S1D–E’). Interestingly, thisbe-negative
hemocytes often correlate with Pxn expression in the lymph gland
periphery, suggesting that thisbe expression may turn off upon
hemocyte differentiation (Fig. S1G–I’). By wandering third instar
stage, high thisbe expression is observed in medial, Heartless+
lymph gland regions (Fig. S1F–F’ and F–F”). We conﬁrmed the
expression of thisbe in hemocyte progenitors of the MZ by
demonstrating overlap of thisbe expression and the MZ marker,
Shotgun (Jung et al., 2005) (Fig. 1G–H”), as well as by the detection
of endogenous transcripts in the MZ (Fig. 1D). A similar pattern of
expression was observed for pyramus transcripts (Fig. 1E). Also at
this late stage, thisbe expression remains largely absent in periph-
eral Pxn+ differentiated hemocytes of the mature CZ (Fig. S1I–I’
and I–I”). In addition to peripheral thisbe−/Pxn+ hemocytes (white
arrows, Fig. S1H–I’), scattered thisbe– cells are also sometimes
observed in medial lymph gland regions, which are undifferen-
tiated (yellow arrows, Fig. S1H–I’). Finally, thisbe expression is also
detected in a subset of Antp+ PSC cells (Fig. 1J–J”). These patterns of
expression for Heartless and its ligands in the lymph gland
suggested a potential role for Heartless signaling in regulating
lymph gland hemocyte progenitors.
Heartless signaling in lymph gland prohemocytes regulates their
differentiation
We next examined the functional role of Heartless in prohe-
mocytes by performing progenitor-speciﬁc loss-of-function and
gain-of-function analyses in the lymph gland. Wild-type (WT)
lymph glands at wandering third instar stage are composed of
4275% Pxn+ hemocytes (Fig. 2A and K). Measuring the proportion
of Pxn-labeled hemocytes in the lymph gland is a good indicator of
relative changes in CZ size and lymph gland differentiation status
(Dragojlovic-Munther and Martinez-Agosto, 2012; Krzemien et al.,
2010; Shim et al., 2012). Speciﬁcally decreasing Heartless signaling
in prohemocytes by overexpression of a dominant-negative
(DN) heartless allele signiﬁcantly decreases the proportion of
Pxn+ differentiated hemocytes in the lymph gland to 2076%
(po0.0001, Fig. 2B and K). Terminally differentiated plasmato-
cytes (labeled with P1) and crystal cells (labeled with Propheno-
loxidase, PPO) are restricted to a thin peripheral layer compared to
wild-type (compare Fig. 2B’ to A’). In addition, a small number of
lamellocytes (L1+) are observed (42% of lymph glands, n¼150,
Fig. 2B”), unlike in wild-type (Fig. 2A”).
Surprisingly, downregulating the expression of the Heartless
ligands, thisbe or pyramus, in lymph gland progenitors had an even
stronger effect on hindering progenitor differentiation, such
that lymph glands are composed of only 1274% or 1175% Pxn+
Fig. 3. Ras, Pointed and U-shaped regulate lymph gland progenitor differentiation. All panels represent wandering third instar. In all panels, dome-Gal4, UAS-2xEGFP (wild-type,
A–A”) is used to express UAS-rasDN (B–B”), UAS-rasAct (C–C”), UAS-rolledAct (D–D”), UAS-pointedRNAi (E–E”), UAS-pointedP2Act (F–F”), UAS-u-shapedRNAi (G–G”) and UAS-u-shapedWT
(H–H”) in prohemocytes (green). Differentiation markers are indicated in A–A” for corresponding rows. (A–A”) Wild-type lymph gland. The populations of peroxidasin (Pxn+)
hemocytes (red, A), plasmatocytes (P1, red) and crystal cells (prophenoloxidase, PPO, blue) (A’) and lamellocytes (L1, red, A”) are labeled. (B–B”) Overexpression of rasDN in
prohemocytes reduces CZ size (B), limiting terminal plasmatocyte and crystal cell differentiation (B’) while allowing rare lamellocytes to differentiate (27% of lymph glands,
n¼115, B”). (C–D”) Overexpression of rasAct (C–C”) or rolledAct (D–D”) in prohemocytes increases CZ size at the expense of the MZ (C and D) and causes plasmatocyte and
crystal cell differentiation in medial lymph gland regions (C’ and D’). Lamellocytes are not observed upon Ras activation (C”), but a small number of lamellocytes differentiate
upon Rolled activation (37% of lymph glands, n¼52, D”). (E–H”) Downregulation of pointed (E) or u-shaped (G) impairs CZ formation and dramatically reduces plasmatocyte
and crystal differentiation (E’ and G’), while inducing signiﬁcant lamellocyte differentiation throughout the lymph gland for both pointedRNAi (86% of lymph glands, n¼66, E”)
and u-shapedRNAi (83% of lymph glands, n¼47, G”). Overexpression of pointedP2Act (F) or u-shapedWT (H) in prohemocytes increases CZ size at the expense of the MZ. While
plasmatocytes and crystal cells are observed throughout the lymph gland (F’ and H’), lamellocytes are not observed (F” and H”). Scale bar¼50 mm and corresponds to all
panels except for the following additional magniﬁcations: X0.9 for F, X0.8 for D and H’, and X0.7 for F’.
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K). Plasmatocytes and crystal cells are likewise restricted to a very
thin peripheral lymph gland layer (Fig. 2C’ and D’). Lamellocytes
are not observed upon thisbe downregulation (Fig. 2C”), but are
detected throughout the lymph gland upon pyramus downregula-
tion, intermixed among the expanded progenitor population
(Fig. 2D”).
In contrast to the reduced differentiation that occurs upon
decreasing Heartless signaling, progenitor-speciﬁc overexpression
of a constitutively active heartless allele (heartlessAct) expands Pxn
expression in the lymph gland (8178%) compared to wild-type
(po0.0001, Fig. 2E and K). Terminally differentiated plasmato-
cytes, crystal cells, and lamellocytes are all observed throughout
the lymph gland (Fig. 2E’–E”). Likewise, forcibly overexpressing
thisbe or pyramus in prohemocytes is sufﬁcient to induce almost
complete differentiation of the lymph gland, such that the propor-
tion of Pxn+ differentiated hemocytes in the lymph gland increases
to 8977% and 8876%, respectively (po0.0001, Fig. 2F, G and K).
Terminally differentiated plasmatocytes and crystal cells are also
detected throughout the lymph gland (Fig. 2F’ and G’), and large
numbers of lamellocytes are induced to differentiate upon thisbe,
but not pyramus, overexpression (Fig. 2F” and G”). The increased
differentiation that occurs upon thisbe or pyramus overexpression
in progenitors is also accompanied by increased size of the lymph
gland primary lobes, compared to wild-type (compare Fig. 2F–G to
A). Likewise, lymph gland secondary lobes, which consist mostly
of undifferentiated dome+ progenitors in wild-type (Fig. 2H),
are severely hypertrophied and differentiated upon both thisbe
and pyramus overexpression in dome+ progenitors (Fig. 2I–J).
Altogether these data demonstrate that Heartless and its ligands,
Thisbe and Pyramus, are necessary and sufﬁcient to promotehemocyte progenitor differentiation in the lymph gland, with
distinct opposing effects on lamellocyte differentiation.
Ras-MAPK, Pointed and U-shaped regulate lymph gland progenitor
differentiation
We next assessed potential downstream regulators of Heartless
in the lymph gland which might mediate the observed differentia-
tion response of hemocyte progenitors. Similar to other receptor
tyrosine kinases, ligand-dependent activation of FGFRs results in
the recruitment of adaptor proteins which can activate multiple
signal transduction pathways (Eswarakumar et al., 2005; Turner
and Grose, 2010). Perhaps the best characterized effector of
activated receptor tyrosine kinase signaling is Ras, which activates
the mitogen activated protein kinase (MAPK) growth signaling
pathway (McKay and Morrison, 2007). We assessed the role of Ras
signaling in the lymph gland via progenitor-speciﬁc overexpres-
sion of a dominant-negative ras allele. Similar to heartless loss-
of-function in prohemocytes (Fig. 2B–B”), rasDN overexpression
reduces the proportion of Pxn+ differentiated hemocytes in the
lymph gland compared to wild-type (20711%, po0.0001, Figs. 2K
and 3B). The populations of plasmatocytes and crystal cells are
also limited to a thin peripheral layer (Fig. 3B’). In addition, rare
lamellocytes are sometimes observed (27% of lymph glands,
n¼115, Fig. 3B”), similar to heartless loss-of-function (Fig. 2B”). In
contrast, overexpressing activated ras or its downstream effector,
rolled, the Drosophila MAPK, in lymph gland prohemocytes
expands the populations of Pxn+ hemocytes, terminally differen-
tiated plasmatocytes and crystal cells throughout the lymph gland
(Figs. 2K, and 3C–C’ and D–D’), at the expense of dome+ progeni-
tors. While lamellocytes are not observed in the lymph gland upon
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lamellocytes differentiate upon Rolled MAPK activation (Fig. 3D”).
A general inhibitor of receptor tyrosine kinase signaling is
Sprouty, which can modulate the pathway at multiple steps
(Mason et al., 2006), and more speciﬁcally has also been shown
to negatively modulate Heartless signaling in Drosophila
(Franzdottir et al., 2009). Sprouty expression is detected through-
out most of the lymph gland at late third instar stages, where it is
expressed in the dome+ MZ progenitor population and most of the
Pxn+ CZ population (Fig. S2A–A”’). Interestingly, downregulation of
sprouty in dome+ prohemocytes increases differentiation in the
lymph gland (Fig. S2C) and also causes a robust increase in
lamellocytes (Fig. S2E, compare to D), similar to progenitor-
speciﬁc Heartless activation (Fig. 2E”). These data are consistent
with a potential role for Sprouty as a negative modulator of
Heartless signaling in lymph gland progenitors.
Transcriptional effects of Heartless and Breathless signaling in
Drosophila can be mediated by the ETS-domain protein, Pointed
(Pnt) (Cabernard and Affolter, 2005; Franzdottir et al., 2009). We
thus hypothesized that Pointed could mediate the strong differ-
entiation phenotypes that occur upon manipulation of Heartless
signaling in prohemocytes downstream of Ras signaling. The
Drosophila pointed gene encodes two protein isoforms, PointedP1
and PointedP2, arising from the use of two alternative promoters
that are separated by 50 kb of genomic sequence (Klambt, 1993;
Scholz et al., 1993). Whereas PointedP1 is a constitutive transcrip-
tional activator, phosphorylation of PointedP2 at Thr151 by MAPK
potently activates PointedP2 transcriptional activity (Brunner
et al., 1994; O’Neill et al., 1994). Consistent with a role for Pointed
downstream of Heartless signaling, downregulation of pointed
expression in dome+ prohemocytes completely blocks CZ forma-
tion, such that the proportion of Pxn+ hemocytes in the lymph
gland is only 271% (Figs. 2K and 3E). While few scattered
plasmatocytes and crystal cells are observed by wandering third
instar stage (Fig. 3E’), a signiﬁcant induction of lamellocytes occurs
upon pointed downregulation (Fig. 3E”), similar to pyramus down-
regulation (Fig. 2D”). Conversely, overexpression of activated Poin-
tedP2 in prohemocytes increases the proportion of Pxn+ lymph
gland hemocytes (80710%, Figs. 2K and 3F) and increases plasma-
tocytes and crystal cells (Fig. 3F’) while not affecting lamellocyte
numbers (Fig. 3F”).
We next examined the function of the transcriptional regulator
U-shaped (Ush), the single Drosophila Friend-of-GATA (FOG) zinc
ﬁnger protein, in lymph gland prohemocytes. Similar to Heartless,
U-shaped function is required for mesoderm migration early in
embryonic development (Fossett et al., 2000). U-shaped has
previously been shown to be expressed within lymph gland
prohemocytes of the MZ as well as within a subset of differen-
tiated plasmatocytes and crystal cells (Gao et al., 2009), yet
prohemocyte-speciﬁc manipulation of u-shaped expression has
not been examined. Remarkably, progenitor-speciﬁc downregula-
tion of u-shaped in lymph gland prohemocytes potently inhibits
lymph gland CZ formation, as the proportion of Pxn+ hemocytes in
the lymph gland is only 674% (Figs. 2K and 3G). Few plasmato-
cytes and rare crystal cells are observed (Fig. 3G’), whereas
induction of lamellocytes occurs throughout the lymph gland
(Fig. 3G”), phenocopying pyramus and pointed downregulation
(Figs. 2D–D” and 3E–E”). Importantly, these data also phenocopy
u-shaped trans heterozygous mutant lymph glands, which have
previously been shown to have decreased plasmatocyte and crystal
cell numbers but increased lamellocytes (Gao et al., 2009). Inter-
estingly, u-shaped trans heterozygous mutant lymph glands demon-
strate ectopic expression of hedgehog (hh), a critical PSC-derived
maintenance signal, in non-PSC cells of the lymph gland, demon-
strating a role for U-shaped in negatively regulating hedgehog
expression in lymph gland hemocytes (Tokusumi et al., 2010).Consistent with these previous ﬁndings, we also observed a robust
increase in hedgehog expression in lymph gland hemocytes upon
progenitor-speciﬁc downregulation of u-shaped (Fig. S3A–D”). While
in wild-type lymph glands, hedgehog expression is observed only in
Antp+ cells of the PSC (Fig. S3A–B”), ectopic expression is observed
upon prohemocyte-speciﬁc u-shaped downregulation in Antp-
negative (Fig. S3C–C”) and Pxn-negative hemocytes (Fig. S3D–D”),
which represents the population of dome+ hemocyte progenitors
(Fig. 3G–G”). While we cannot rule out that this increased expres-
sion of hedgehog throughout the lymph gland may contribute to the
increased progenitor maintenance observed upon u-shaped down-
regulation (Fig. 3G–G”), previous studies have already demonstrated
that increasing hedgehog expression in the MZ, outside of the
context of the PSC, is not sufﬁcient to expand the progenitor
population (Tokusumi et al., 2010). Converse to u-shaped down-
regulation, overexpression of wild-type u-shaped in dome+ progeni-
tors increases the proportion of Pxn+ differentiated hemocytes in
the lymph gland to 8076% (Figs. 2K and 3H). The populations of
plasmatocytes and crystal cells expand to more medial lymph gland
regions (Fig. 3H–H’), whereas lamellocytes are not observed
(Fig. 3H”). Collectively, these ﬁndings demonstrate a role for Ras
signaling and Pointed/ETS and U-shaped/FOG transcription factor
function in blood cell differentiation.
Clonal disruption of Heartless-Ras-Pointed signaling affects lymph
gland hemocyte differentiation
Our results demonstrate robust effects on lymph gland differ-
entiation and CZ formation upon manipulation of Heartless, its
ligands (Fig. 2), and its potential downstream intracellular path-
way components (Fig. 3) within the total population of prohemo-
cytes. We next conﬁrmed our ﬁndings by manipulating Heartless
signaling in lymph gland-speciﬁc clonal populations of hemocytes.
HHLT (hand-hml lineage-traced Gal4) (Evans et al., 2009) generates
wild-type clones that are often very large, and span most of the
Pxn– MZ (Fig. S4A–A”) as well as a proportion of Pxn+ CZ cells
(yellow cells, Fig. S4A”). Clonally overexpressing heartlessDN in
lymph gland hemocytes impairs differentiation, such that clonal
cells minimally overlap with the early differentiation marker, Pxn
(Fig. S4B–B”). Likewise, lymph gland-speciﬁc clonal downregula-
tion of thisbe or pyramus strongly impairs differentiation, limiting
it to surrounding wild-type cells at the lymph gland periphery
(red, Pxn+) and demonstrating absence of overlap of Pxn with
mutant cells (Fig. S4C–D”). In addition to generating large clones
that often span the entire MZ (Fig. S4C–D”), we also generated
small FLP-FRT mutant clones for pyramus, in order to assess
whether activation of Heartless signaling by its ligands could be
cell-autonomous. Pyramus mutant clones in peripheral lymph
gland regions did not block differentiation (Fig. S5B–B”’), whereas
more medial pyramus mutant clones remain undifferentiated
(Fig. S5C–C”’). These data are consistent with the diffusible nature
of FGF growth factors, and suggests that adjacent wild-type cells
that express the ligand are sufﬁcient to rescue the mutant clone
cells. In contrast, downregulation of the ligands throughout the
entire progenitor population (dome-gal4, Fig. 2C–D”) or in large
lymph gland-speciﬁc clones (HHLT, Fig. S4C–D”) is sufﬁcient to
hinder differentiation. Conversely, activation of Heartless signaling
in lymph gland hemocytes via clonal overexpression of heartlessAct,
thisbeWT, or pyramusWT strongly induces differentiation, such that
Pxn expression is robustly upregulated within mutant cells (yel-
low, Fig. S4E–G”), conﬁrming their role in promoting hemocyte
differentiation.
Similar to reduced Heartless signaling (Fig. S4B–D”), clonally
impairing Ras activity in the lymph gland blocks differentiation
of mutant cells, while surrounding wild-type cells differentiate
(Fig. S4H–H”). Conversely, clonal activation of Ras or Rolled MAPK
Fig. 4. Heartless-Ras-Pointed mutant clonal analysis demonstrates impaired plasmatocyte and crystal cell differentiation. All panels represent wandering third instar. The
plasmatocyte marker, P1, is labeled in red in panels A–D”, whereas the crystal cell marker prophenoloxidase (PPO) is labeled in red in panels E–H”, and the lamellocyte maker
L1 is labeled in red in panels I–L. Wild-type (A–A”, E–E” and I) and mutant (B–D”, F–H” and J–L) MARCM clones are shown in green. (A–A”, E–E” and I) Wild-type MARCM clones
(hs-ﬂp FRT82B Tub-mCD8-GFP) in peripheral lymph gland regions demonstrate overlap (yellow) with terminally differentiated plasmatocyte (A–A”) and crystal cell (E–E”)
lineage markers, but are negative for lamellocytes (I). (B–D”, F–H” and J–L) MARCM clones for heartlessAB42 [hs-ﬂp FRT82B heartlessAB42 FRT82B Tub-mCD8-GFP (B–B”, F–F” and J)],
pointedΔ88 [hs-ﬂp FRT82B pointedΔ88 FRT82B Tub-mCD8-GFP (C–C”, G–G” and K)] or rasΔC40B [hs-ﬂp FRT82B rasΔC40B FRT82B Tub-mCD8-GFP (D–D”, H–H” and L)] in peripheral lymph
gland regions demonstrate minimal overlap with terminally differentiated plasmatocyte (B–D”) and crystal cell (F–H”) lineage markers. Whereas lamellocytes are observed in
pointedΔ88 clones (K), no lamellocytes are detected in heartlessAB42(J) or rasΔC40B (L) clones. Scale bars¼50 mm. Scale bar in A corresponds to panels A–D”; scale bar in E
corresponds to panels E–H”; scale bar in I corresponds to I–L.
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cells (yellow cells, Fig. S4I–J”). Similarly, the requirement for
Pointed activity in regulating differentiation of lymph gland
progenitors (Fig. 3E–E”) was further demonstrated by the strong
block in differentiation of clonal cells expressing pointedRNAi,
which populate almost the entire lymph gland (Fig. S4K–K”).
Furthermore, lymph gland-speciﬁc clonal downregulation of u-
shaped blocks differentiation in clonal cells, whereas adjacent
wild-type cells differentiate (Fig. S4M–M”). Finally, clonal activa-
tion of PointedP2 (Fig. S4L–L”) or overexpression of wild-typeFig. 5. Pointed and U-shaped function downstream of Heartless in lymph gland progenitors
gal4, UAS-2xEGFP, UAS-FLP; A5C-FRT-STOP-FRT-gal4) is used to clonally express the speci
2xEGFP is used to express the speciﬁed genetic constructs in dome+ prohemocytes. GF
expression is shown in red. (A) Wild-type lymph gland. Wild-type clonal cells (gre
Overexpression of heartlessAct (htlAct, B), thisbeWT (thsWT, D), or pyramusWT (pyrWT, F) i
Downregulation of pointed (pnt) upon overexpression of heartlessAct (htlAct; pntRNAi, C), this
block the differentiation response of hemocytes normally observed upon overexpression
Wild-type expression of dome (green) in the MZ and Pxn (red) in the CZ. (I–N) Overexp
(pyrRNAi, M) in prohemocytes impairs prohemocyte differentiation and CZ formation. Ove
(thsRNAi; pntP2Act, L) or pyramusRNAi (pyrRNAi; pntP2Act, N) expression in prohemocytes
overexpression of heartlessAct (htlAct, O), thisbeWT (thsWT, Q), or pointedP2Act (pntP2Act,
Downregulation of u-shaped (ush) upon overexpression of heartlessAct (htlAct; ushRNAi, P)
impairs their differentiation, hindering CZ formation. (U) Quantiﬁcation of Pxn+ hemo
mean7s.d., n¼10. Asterisks denote statistical signiﬁcance compared to wild-type (domu-shaped (Fig. S4N–N”) robustly induces differentiation in
clonal cells.
We next explored the cell-autonomous requirement of Heartless
and its downstream components in regulating differentiation by
generating homozygous loss-of-function MARCM mutant clones for
heartless, ras, or pointed. In all three cases mutant clones demon-
strated an absence of terminal differentiation markers for plasma-
tocytes (P1) and crystal cells (PPO) in peripheral lymph gland
regions, where adjacent wild-type cells differentiate (Fig. 4B–D”
and F–H”). In contrast, wild-type clonal cells demonstrate overlap of. All panels represent wandering third instar. In panels A–G, HHLT (hand-gal4, hml-
ﬁed genetic constructs in lymph gland hemocytes. In panels H–T, dome-Gal4, UAS-
P (green) labels clonal cells in A–G and prohemocytes in H–T. Peroxidasin (Pxn)
en) express Pxn (red) only in peripheral CZ regions (overlap in yellow). (B–G)
n lymph gland hemocytes robustly increases differentiation in the lymph gland.
beWT (thsWT; pntRNAi, E), or pyramusWT (pyrWT; pntRNAi, G) is sufﬁcient to dramatically
of heartlessAct (B), thisbeWT (D), or pyramusWT (F) alone. (H) Wild-type lymph gland.
ression of heartlessDN (htlDN, I) or downregulation of thisbe (thsRNAi, K) or pyramus
rexpression of pointedP2Act (pntP2Act) upon heartlessDN (htlDN; pntP2Act, J), thisbeRNAi
is sufﬁcient to induce their precocious differentiation. (O–T) Progenitor-speciﬁc
S) increases differentiation in the lymph gland at the expense of prohemocytes.
, thisbeWT (thsWT; ushRNAi, R), or pointedP2Act (pntP2Act; ushRNAi, T) in prohemocytes
cyte population distribution (% area) in the lymph gland. Data are represented as
e4), measured by Student’s t-test. Scale bars¼50 mm.
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regions. Only pointed mutant clones demonstrated lamellocyte
differentiation (Fig. 4K), consistent with the effects on lamellocyte
differentiation induced by pointed downregulation in progenitors
(Fig. 3E”). While disruption of heartless or ras function in clones
(Fig. 4J and L) did not induce lamellocyte formation, this is likely due
to the smaller number of hemocytes genetically disrupted, compared
to dome-gal4-mediated disruption of the entire progenitor popula-
tion (Figs. 2B” and 3B”). Taken together, our HHLT and MARCM clonal
analyses demonstrate the cell-autonomous requirement of Heartless
and its potential downstream effectors Ras, Pointed and U-shaped in
regulating lymph gland hemocyte differentiation.Receptor tyrosine kinase signaling effects on differentiation are
speciﬁc to Pyramus and Thisbe
Our ﬁndings suggest that canonical Ras-MAPK signaling
through Pointed may mediate the effects of activated Heartless
signaling in the lymph gland. Previous studies have demonstrated
functional roles of other receptor tyrosine kinases in circulating
hemocytes (Munier et al., 2002; Zettervall et al., 2004) as well as in
the lymph gland, including epidermal growth factor receptor
(EGFR) (Sinenko et al., 2012) and the Drosophila platelet derived
growth factor/vascular endothelial growth factor (PDGF/VEGF)
receptor homolog, PVR (Mondal et al., 2011). In order to assess
the speciﬁcity of Thisbe and Pyramus in inducing progenitor
differentiation, we monitored the effects on cell populations upon
forcibly overexpressing other receptor tyrosine kinase ligands in
lymph gland progenitors.
Progenitor-speciﬁc overexpression of branchless, the third Dro-
sophila FGF ligand that speciﬁcally activates the Breathless recep-
tor, does not alter lymph gland differentiation (Fig. S6B and K),
demonstrating speciﬁcity for Heartless and its ligands in mediat-
ing lymph gland progenitor differentiation. While the receptor
tyrosine kinase EGFR is expressed in the lymph gland (JA Marti-
nez-Agosto, unpublished results, and Sinenko et al., 2012), forcibly
overexpressing the EGFR ligands, vein, spitz, gurken, or keren in
dome+ prohemocytes is not sufﬁcient to affect lymph gland
differentiation (Fig. S6C–F and K), and neither is overexpression
of the anaplastic lymphoma kinase (ALK) ligand, jelly-belly
(Fig. S6G and K). Finally, recent studies have demonstrated PVR
expression in MZ prohemocytes (Mondal et al., 2011). The PVR
ligand, Pvf1, is expressed in PSC cells, whereas Pvf2 is expressed in
PSC and the most medial MZ cells (Mondal et al., 2011). While
overexpression of pvf1 in lymph gland progenitors does not induce
a differentiation response (Fig. S6H and K), pvf2 overexpression is
sufﬁcient to induce almost complete differentiation of the lymph
gland (Fig. S6I and K). In contrast, downregulation of pvf2 in the
MZ has no effect on progenitor differentiation (Mondal et al.,
2011), suggesting that Pvf2 is not required to induce differentia-
tion during normal lymph gland development, but is sufﬁcient to
induce a differentiation response upon increased ligand expres-
sion. Pvf2 signals independently from Heartless in blood progeni-
tors, as reducing Heartless function in prohemocytes upon pvf2
overexpression does not impair the differentiation response
observed upon pvf2 overexpression alone (Fig. S6J, compare to I).
Our data thus identify two independent positive effectors of
differentiation in lymph gland prohemocytes, one that is necessary
and sufﬁcient for normal hemocyte differentiation and the other
able to promote differentiation exclusively upon overexpression.
From these experiments, we conclude that the requirement of
Thisbe and Pyramus in lymph gland progenitors for their differ-
entiation is not a general response of activating receptor tyrosine
kinase signaling, but is speciﬁc to Heartless signaling.Pointed and U-shaped function downstream of Heartless in lymph
gland progenitors
We next determined the function of Pointed downstream of
Heartless signaling in mediating lymph gland hemocyte differen-
tiation by performing epistasis analysis. Lymph gland-speciﬁc
downregulation of pointed upon overexpression of heartlessAct is
sufﬁcient to block the differentiation response of Heartless activa-
tion alone (compare Fig. 5B–C) and hinder hemocyte differentia-
tion, similar to pointed downregulation alone (Fig. S4K”). Likewise,
downregulation of pointed upon thisbe or pyramus overexpression
also effectively hinders hemocyte differentiation (Fig. 5D–G),
suggesting that the differentiation response downstream of acti-
vated Heartless signaling in the lymph gland is dependent on
Pointed activity.
We next assessed the importance of Pointed function down-
stream of Heartless signaling by examining the sufﬁciency of
PointedP2 activation to induce differentiation in conditions of
reduced Heartless signaling. Co-expression of pointedP2Act with
heartlessDN, thisbeRNAi, or pyramusRNAi in dome+ prohemocytes is
sufﬁcient to signiﬁcantly increase lymph gland differentiation in
these backgrounds (Fig. 5I–N). Importantly, the proportion of Pxn+
hemocytes in these backgrounds (72711%, 71710%, or 67711%,
respectively; Fig. 5U) is similar to progenitor-speciﬁc pointedP2Act
overexpression alone (80710%; Fig. 2K).
Given the lack of differentiation observed upon u-shaped down-
regulation (Figs. 3G–G” and S4M–M”) and reduction in Heartless
signaling (Figs. 2B–D” and S4B–D”), we examined whether U-shaped
also functions downstream of Heartless signaling in the lymph
gland. Downregulating u-shaped upon overexpression of heartlessAct
or thisbeWT in dome+ hemocyte progenitors signiﬁcantly reduces
progenitor differentiation in the lymph gland (Fig. 5P and R)
compared to overexpression of heartlessAct or thisbeWT alone
(Fig. 5O and Q). The proportion of Pxn+ hemocytes in these
backgrounds is dramatically decreased (1676% and 20710%,
respectively; Fig. 5U), compared to heartlessAct or thisbeWT over-
expression alone (8178% and 8977%, respectively; Fig. 2K). Hav-
ing demonstrated that reducing either pointed or u-shaped
expression in the lymph gland is sufﬁcient to rescue differentiation
phenotypes induced by activated Heartless signaling, we next
examined the epistatic relationship of U-shaped and Pointed in
MZ prohemocytes. Interestingly, downregulation of u-shaped upon
pointedP2Act overexpression in dome+ progenitors dramatically
impairs progenitor differentiation in the lymph gland (Fig. 5S–T),
phenocopying u-shapedRNAi alone (Fig. 3G), and dramatically
reduces the proportion of Pxn+ hemocytes in the lymph gland to
only 775% (Fig. 5U).
Altogether, our epistasis analyses demonstrate that Pointed/ETS
activation downstream of Heartless signaling mediates the effects of
Thisbe/Pyramus-Heartless signaling on hemocyte progenitor differ-
entiation. Our data also describes U-shaped/FOG as a potent effector
of differentiation, which either functions downstream of Pointed or
is required for Pointed activity in mediating the Heartless-induced
differentiation response of hemocyte progenitors.
Activation of target of rapamycin (TOR) signaling upon Heartless
activation
Target of rapamycin (TOR) complex 1 (TORC1) signaling in
Drosophila lymph gland progenitors regulates their early prolifera-
tion during second and early third instar stages and later differ-
entiation (Dragojlovic-Munther and Martinez-Agosto, 2012).
Interestingly, activation of TORC1 through disruption of the TORC1
pathway inhibitor, tuberous sclerosis complex 1/2 (tsc1/2), in lymph
gland progenitors induces signiﬁcant lamellocyte differentiation
(Dragojlovic-Munther and Martinez-Agosto, 2012), similar to the
Fig. 6. Activation of target of rapamycin (TOR) signaling by Thisbe and Heartless. All panels represent wandering third instar. In all panels, dome-Gal4, UAS-2xEGFP (wild-type,
A–A”, E and M) is used to express the speciﬁed genetic constructs in prohemocytes (green). Phoshphorylated 4EBP (p4EBP) is labeled in red in panels A’–D”, peroxidasin (Pxn)
is labeled in red in panels E–L, and the lamellocyte marker L1 is labeled in red in panels M–U. (A–A”) Wild-type lymph gland. P4EBP (red) is expressed at low levels in medial
regions of the lymph gland. (B–D”) Overexpression of heartlessAct (B–B”) or thisbeWT (C–C”) in prohemocytes robustly increases p4EBP levels (red) throughout the lymph gland,
whereas pyramusWT overexpression (D–D”) does not. (E) Wild-type lymph gland. (F) Reducing target of rapamycin complex 1 (TORC1) signaling via systemic rapamycin
treatment increases CZ (red) size at the expense of the MZ. (G–J) Overexpression of heartlessAct (G) or thisbeWT (I) in prohemocytes robustly increases differentiation in the
lymph gland, which is partially reduced following rapamycin treatment (H and J). (K–L) Overexpression of pyramusWT in hemocyte progenitors robustly increases
differentiation throughout the lymph gland (K), which is not affected by systemic rapamycin treatment (L). (M–O) Whereas lamellocytes are not observed in wild-type lymph
glands (M), overexpression of heartlessAct (N) or thisbeWT (O) in prohemocytes robustly induces lamellocyte differentiation throughout the lymph gland. (P–U) A small
number of lamellocytes are sometimes observed upon systemic rapamycin treatment (48% of lymph glands, n¼50, P) or progenitor-speciﬁc overexpression of d4EBP(LL) (36%
of lymph glands, n¼44, S), yet both conditions are sufﬁcient to strongly impair the robust increase in lamellocyte differentiation (seen in N and O) in both heartlessAct (Q and
T) and thisbeWT (R and U) overexpressing lymph glands. (V) Quantiﬁcation of Pxn+ hemocyte population distribution (% area) in the lymph gland. Data are represented as
mean7s.d., n¼10. Asterisks denote statistical signiﬁcance between indicated genotypes/treatments, measured by Student’s t-test. Scale bars¼50 mm.
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(Fig. 2E” and F”). Given that lamellocytes are not observed in the
lymph gland upon progenitor-speciﬁc Ras or Pointed activation
(Fig. 3C” and F”), we reasoned that a distinct intracellular signaling
pathway might mediate the lamellocyte differentiation induced by
Thisbe–Heartless signaling and examined the possibility that it
could be TORC1-mediated. In wild-type lymph glands, phosphory-
lated translation initiation factor 4E-binding protein (p4EBP),
a marker of active TORC1 signaling, is expressed at low levels in
the lymph gland (Fig. 6A–A”, Dragojlovic-Munther and Martinez-
Agosto, 2012). Overexpression of heartlessAct or thisbeWT in hemo-
cyte progenitors robustly increases p4EBP expression throughoutthe lymph gland, demonstrating activation of mTORC1 signaling
upon Thisbe-mediated Heartless signaling (Fig. 6B–C”). In contrast,
overexpression of pyramusWT in hemocyte progenitors does not
signiﬁcantly change p4EBP levels in the lymph gland compared to
wild-type (compare Fig. 6D–D” to A–A”), demonstrating a lack of
TORC1 activation downstream of pyramus overexpression.
We next examined the TORC1-dependence of Heartless- and
Thisbe-induced phenotypes by treating larvae with the TORC1
inhibitor, rapamycin. Systemic rapamycin treatment of wild-type
larvae increases differentiation in the lymph gland (compare
Fig. 6F to E) (Dragojlovic-Munther and Martinez-Agosto, 2012;
Shim et al., 2012), signiﬁcantly increasing the proportion of Pxn+
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wild-type, Fig. 6V). Interestingly, rapamycin treatment partially
restores lymph gland zonation upon overexpression of heartlessAct
in hemocyte progenitors (compare Fig. 6H to G), signiﬁcantly
reducing the proportion of Pxn+ hemocytes in the lymph gland
(5678%) compared to heartlessAct overexpression alone (po0.0001,
Fig. 6V). While rapamycin treatment also reduces the proportion of
Pxn+ hemocytes in the lymph gland upon thisbe overexpression
(63710%), compared to thisbe overexpression alone (po0.0001,
Fig. 6I–J and V), rapamycin does not affect differentiation under
conditions of pyramus overexpression (p40.05, Fig. 6K–L and V).
Importantly, rapamycin treatment is sufﬁcient to largely block the
lamellocyte differentiation normally observed upon progenitor-
speciﬁc heartlessAct or thisbeWT overexpression (compare Fig. 6Q–R
to N–O), despite the small lamellocyte differentiation that occurs in
the lymph gland upon rapamycin treatment of wild-type larvae
(Fig. 6P). Similar to pyramus overexpression alone (Fig. 2G”), lamel-
locytes are never observed in the lymph gland following rapamycin
treatment (data not shown).
Our previous studies identiﬁed 4EBP as a potent effector of
TORC1-dependent phenotypes in Drosophila hemocyte progenitors
(Dragojlovic-Munther and Martinez-Agosto, 2012). Phosphoryla-
tion of 4EBP by TORC1 promotes growth by relieving translation
initiation factor 4E (IF-4E) from inhibitory 4EBP binding (Gingras
et al., 2001). Similar to systemic rapamycin treatment, progenitor-
speciﬁc overexpression of a mutant form of Drosophila 4EBP
[d4EBP(LL)] that binds more tightly to IF-4E and thus inhibits
TOR-dependent effects increases the proportion of Pxn+ hemo-
cytes in the lymph gland to 5576% (po0.0001 compared to wild-
type, Figs. 6V and S7B). Overexpression of d4EBP(LL) upon heart-
lessAct or thisbeWT overexpression in progenitors is also sufﬁcient to
impair lamellocyte differentiation (Fig. 6T–U) and affects the
proportion of Pxn+ hemocytes (Figs. 6V and S7C–D), similar to
rapamycin treatment. Together, these results suggest that the
dramatic expansion of lamellocytes observed upon progenitor-
speciﬁc Heartless activation or thisbe overexpression is mediated
by active TORC1 signaling through 4EBP, rather than Ras-Pointed
signaling, which is required for plasmatocyte differentiation. The
failure of pyramus overexpression to induce a similar TORC1-
dependent response highlights the context-speciﬁc signaling of
Heartless ligands in Drosophila.
Regulation of Heartless signaling in the lymph gland by heparan
sulfate proteoglycans
Intriguingly, thisbe and pyramus expression in the lymph gland
is highest in the MZ (Fig. 1), and overexpressing thisbe or pyramus
ligands in the progenitor population is sufﬁcient to induce almost
complete differentiation of the lymph gland (Fig. 2F–G and K). We
reasoned that Heartless ligand signaling in lymph gland progeni-
tors must be tightly regulated, both to allow the progression of
differentiation of peripheral progenitors that go on to populate the
maturing CZ during development, and also to prevent the pre-
mature differentiation of medial prohemocytes before the onset of
metamorphosis, when MZ progenitors differentiate and enter
circulation (Grigorian et al., 2011b). One candidate modulator of
Heartless signaling in the lymph gland is the Drosophila Perlecan
homolog, Terribly Reduced Optic Lobes (Trol), a member of the
heparan sulfate proteoglycan family (Park et al., 2003). Perlecans
are mainly distributed in the extracellular matrix and exclusively
have heparan sulfate chains (Perrimon and Bernﬁeld, 2000).
Fibroblast growth factor signaling is among the most well char-
acterized pathways regulated by heparan sulfate proteoglycans,
which can serve at least two context-dependent functions in
regulating signaling through FGF receptors. First, heparan sulfate
proteoglycans can serve as a co-factor that stabilizes the FGF/FGFRinteraction. Secondly, binding of FGF ligands to highly sulfated
heparan sulfate sequences can sequester FGFs, regulate their
movement and diffusibility in the extracellular matrix, and also
protect them from proteolytic degradation (Dowd et al., 1999;
Saksela et al., 1988).
Previous studies have demonstrated that a dense Trol-positive
extracellular matrix reticulum surrounds progenitors in the MZ at
later third instar stages (Grigorian et al., 2011b). We hypothesized
that signaling of FGF ligands in the lymph gland might be
modulated spatially and/or temporally through Trol. Surprisingly,
trol downregulation in prohemocytes increases differentiation in
the lymph gland (68714% Pxn+ hemocytes, Fig. 7B and I,
compared to wild-type, Fig. 7A). Importantly, trol mutant lymph
glands also present with robust differentiation and reduction of
the undifferentiated progenitor population (Grigorian et al., this
issue), supporting our ﬁndings that reduced trol expression
induces precocious lymph gland differentiation. We next exam-
ined whether this increased differentiation can be attributed to
excessive Heartless signaling in the lymph gland. Reducing expres-
sion of thisbe or pyramus upon downregulation of trol in progeni-
tors is sufﬁcient to signiﬁcantly reduce the proportion of Pxn+ cells
in the lymph gland (3178% and 2978%, respectively, Fig. 7D, F
and I) compared to wild-type (po0.05) or downregulation of trol
alone (po0.0001). However, the proportion of Pxn+ hemocytes in
these backgrounds is also signiﬁcantly higher than thisbe or
pyramus downregulation alone (po0.0001, Figs. 2K and 7C and E).
These results suggest that the increased availability of one ligand
partially compensates for the downregulation of the other in condi-
tions of reduced trol expression, and that Trol sequesters both ligands
in the extracellular matrix. Furthermore, overexpression of heartlessDN
upon progenitor-speciﬁc trol downregulation is sufﬁcient to signiﬁ-
cantly decrease the proportion of Pxn+ hemocytes (2578%, Fig. 7H–I)
compared to wild-type or trol downregulation alone (po0.0001), and
is not signiﬁcantly different than overexpression of heartlessDN alone
(2076%, p40.05, Figs. 2K and 7G). This ﬁnding further suggests that
the differentiation observed upon trol downregulation is mediated by
Heartless activation via both its ligands, Thisbe and Pyramus.
We also examined Trol expression at earlier stages, when
differentiation is just initiating in the developing lymph gland. In
contrast to wandering third instar lymph glands, wherein high
Trol expression is detected in the extracellular matrix surrounding
MZ progenitors (Pxn–) but is absent in the peripheral CZ (Pxn+,
inset, Fig. 7J), high Trol levels extend to the lymph gland periphery
during the second larval instar stage (Fig. 7K). We also observed
large pockets of Trol-negative tissue in the lymph gland periphery
which contained groups of early differentiating hemocytes during
this stage (inset, Fig. 7K). Interestingly, increased differentiation in
the lymph gland associated with progenitor-speciﬁc trol down-
regulation is already observed by the second and early third instar
stages (Fig. 7M and O), compared to wild-type (Fig. 7L and N),
culminating in the observed phenotype at wandering third instar
(Fig. 7B). Altogether, our data suggest that Trol modulates Heart-
less signaling in the lymph gland to prevent precocious prohemo-
cyte differentiation. This likely occurs via sequestration of
Heartless ligands, Thisbe and Pyramus, in the extracellular matrix
until they are required to induce hemocyte differentiation during
lymph gland development.Discussion
In this study we highlight a crucial role for the Drosophila
ﬁbroblast growth factor receptor (FGFR), Heartless, in maintaining
the homeostatic balance of MZ prohemocytes and differentiated
hemocytes of the CZ. Whereas activation of Heartless signaling
in blood progenitors dramatically increases differentiation at the
Fig. 7. Regulation of FGF signaling in the lymph gland by Trol. Panels A–H represent wandering third instar. In panels A–H and L–O, dome-Gal4, UAS-2xEGFP (wild-type, A, L and N)
is used to express the speciﬁed genetic constructs in prohemocytes (green). In panels J–K, the protein trap line ZCL1973X labels endogenous Trol-GFP protein fusion expression.
In all panels peroxidasin (Pxn) expression is shown in red. (A) Wild-type lymph gland. (B) Downregulating trol expression in prohemocytes induces their differentiation into
Pxn+ hemocytes, increasing CZ size at the expense of the MZ. (C–H) Progenitor-speciﬁc downregulation of thisbe (thsRNAi, C) or pyramus (pyrRNAi, E) or overexpression of
heartlessDN (htlDN, G) reduces differentiation (red), impairing CZ formation. Downregulation of thisbe (thsRNAi; trolRNAi, D) or pyramus (pyrRNAi; trolRNAi, F) or overexpression of
heartlessDN (htlDN; trolRNAi, H) upon downregulation of trol is sufﬁcient to block the increased differentiation induced by trol downregulation alone (B).
(I) Quantiﬁcation of Pxn+ hemocyte population distribution (% area) in the lymph gland. Data are represented as mean7s.d., n¼10. Asterisks denote statistical signiﬁcance
compared to wild-type (dome4), measured by Student’s t-test. (J) At wandering third instar stage (wL3), high levels of Trol are detected in the extracellular matrix amidst the
population of Pxn– hemocytes of the MZ, but Trol expression is not observed among Pxn+ hemocytes (red) of the CZ (inset). (K) During the second larval instar stage (L2), high
levels of Trol are observed in the extracellular matrix throughout the lymph gland. Large pockets of Trol-negative tissue outline groups of early differentiating (Pxn+) hemocytes.
(L–O) Wild-type lymph glands at second instar (L2, L) contain a small population of early differentiating hemocytes, which increases by early third instar stage (eL3, N) to begin
forming the early CZ. Downregulation of trol in prohemocytes expands the population of differentiating hemocytes during second and early third instar stages (M and O,
respectively) compared to wild-type. (P) Thisbe/Pyramus-Heartless signaling in Drosophila lymph gland hemocyte progenitors. Thisbe- and Pyramus-induced Heartless (Htl)
activation in lymph gland progenitors is modulated by Trol/Perlecan heparan sulfate proteoglycan. Heartless activation by its ligands induces plasmatocyte differentiation in a
Pointed/ETS-dependent manner through Ras activation, affecting the ratio of MZ progenitors and CZ differentiated hemocytes in the lymph gland. U-shaped/FOG is also required
for Heartless- and Pointed-mediated effects on differentiation and functions either downstream of or in parallel to Heartless signaling. Thisbe-speciﬁc Heartless activation
induces lamellocyte differentiation in a TORC1-dependent manner that is independent of Pointed or U-shaped gain-of-function and is also not observed upon pyramus
overexpression. Scale bars¼50 mm. Scale bar in A corresponds to panels A–H, except for the following additional magniﬁcations: X0.75 for E, X0.8 for B and H, and X1.2 for D.
Scale bar in L corresponds to L–M. Scale bar in N corresponds to N–O.
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impairs CZ formation. To date, the signals that induce progenitor
differentiation and CZ formation during larval lymph glanddevelopment remain largely unknown. Hyperactivation of the
target of rapamycin complex 1 (TORC1) signaling pathway by
progenitor-speciﬁc downregulation of the TORC1 pathway
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lymph gland differentiation at late larval stages (Dragojlovic-
Munther and Martinez-Agosto, 2012). Surprisingly, however,
inhibition of TORC1 signaling also increases differentiation in the
lymph gland at the expense of prohemocytes, demonstrating
that both loss-of-function and gain-of-function of TORC1 signaling
promotes progenitor differentiation (Benmimoun et al., 2012;
Dragojlovic-Munther and Martinez-Agosto, 2012). Furthermore,
while overexpression of the PVR ligand, pvf2, autonomously
increases progenitor differentiation (this study), downregulation
of pvf2 in progenitors does not affect their differentiation (Mondal
et al., 2011). These ﬁndings demonstrate that neither Pvf2 nor
TORC1 signaling are actually required for lymph gland progenitor
differentiation during development. In contrast, our analysis of
Pyramus/Thisbe-Heartless signaling through Pointed uncovers a
signaling network that is not only sufﬁcient, but is also required,
for progenitor differentiation into both plasmatocytes and crystal
cells, as well as proper CZ formation in the lymph gland.
Distinct roles of Ras signaling in lymph gland hemocyte populations
Previous studies in Drosophila hematopoiesis have identiﬁed
Ras as a potent effector of differentiated hemocyte proliferation,
demonstrating dramatic increases in circulating hemocyte popula-
tion numbers upon Ras activation (Asha et al., 2003; Evans et al.,
2007; Zettervall et al., 2004). In this study we examined
prohemocyte-speciﬁc Ras activation in the lymph gland, allowing
dissection of a distinct role for Ras activity in Drosophila larval
hematopoiesis. Prohemocyte-speciﬁc Ras activation in the lymph
gland induces their precocious differentiation, expanding CZ size
at the expense of the MZ (Fig. 3). In contrast to its proliferative
effects on embryo-derived circulating hemocytes, Ras activation in
lymph gland prohemocytes does not affect lymph gland size
(Fig. 3), as would be expected of a signal that drastically increases
cell proliferation in mature hemocytes (Asha et al., 2003; Evans
et al., 2007; Zettervall et al., 2004). Unlike prohemocyte-speciﬁc
Ras activation, clonal Ras activation in the lymph gland autono-
mously induces hemocyte differentiation and also robustly
increases lymph gland tissue size (Fig. S4I–I”). This increase in
tissue size is likely due to the sustained expression of the activated
ras allele in differentiated clonal hemocytes. Our data thus
describe a transition in Ras function in the lymph gland, wherein
Heartless-induced Ras activation in hemocyte progenitors initially
regulates their differentiation, after which, activation of Ras
promotes proliferation of differentiated hemocytes, which may
contribute to increasing CZ hemocyte numbers at late larval stages
(Jung et al., 2005). Potential candidates for Ras activation in
differentiated cortical hemocytes are epidermal growth factor
receptor (EGFR), anaplastic lymphoma kinase (ALK), and/or PVR,
which all induce differentiated hemocyte proliferation (Zettervall
et al., 2004), but do not autonomously regulate progenitor differ-
entiation in the MZ (Fig. S6). Interestingly, however, reducing
Ras or Pointed activity in hemocyte progenitors moderately
reduces total lymph gland size compared to wild-type, although
the sizes of the MZ prohemocyte populations are similar to
wild-type (Fig. 3). It is thus likely that the reduced tissue size is
not the result of reduced progenitor proliferation, but rather due
to the absence of CZ formation, as proliferation of differentiated
cortical hemocytes contributes to expansion of the CZ during third
instar stages and in turn affects total lymph gland size (Jung et al.,
2005).
The mechanisms that operate to regulate the population of
undifferentiated dome+ hemocyte progenitors in the lymph gland
secondary lobes have not been characterized, but maintenance of
this hemocyte population provides a reservoir of progenitors
during larval development. Our functional analyses of Pyramusand Thisbe in dome+ progenitors demonstrated the sufﬁciency of
these ligands to autonomously induce robust differentiation of the
lymph gland secondary lobes, similar to their phenotypic effects in
the dome+ progenitor population of the lymph gland primary lobes
(Fig. 2). Further, pyramus and thisbe overexpression in dome+
progenitors is sufﬁcient to induce severe hypertrophy of the lymph
gland secondary lobes and also causes increased primary lobe size.
Since activation of Ras in dome+ hemocyte progenitors does not
affect lymph gland size (Fig. 3) but has robust affects on differ-
entiated hemocyte proliferation, we hypothesize that forcibly
overexpressing pyramus and thisbe in lymph gland hemocyte
progenitors could promote proliferation and expansion of the
population of differentiated hemocytes which in turn could con-
tribute to lymph gland tissue overgrowth in the primary and
secondary lobes.
Heartless signaling in the lymph gland is mediated by Pointed and U-
shaped
Distinct roles in speciﬁc hemocyte populations have been
identiﬁed for the single Drosophila Friend-of-GATA (FOG) tran-
scriptional regulator, U-shaped, during hematopoiesis. These
include roles as regulator of crystal cells (Fossett et al., 2001),
hemocyte number (Sorrentino et al., 2007), lamellocyte transfor-
mation (Avet-Rochex et al., 2010), and a negative regulator of
hedgehog expression in lymph gland hemocytes (Tokusumi et al.,
2010). U-shaped is strongly expressed in the lymph gland MZ,
and it has previously been proposed to regulate prohemocyte
maintenance (Gao et al., 2009). In this study we performed
prohemocyte-speciﬁc downregulation of u-shaped in the lymph
gland, which dramatically increases the size of the dome+ MZ
prohemocyte population at the nearly complete expense of cor-
tical plasmatocytes and crystal cells, yet also induces lamellocyte
differentiation (Fig. 3). These data phenocopy previous loss-of-
function studies that have demonstrated a reduction of plasmato-
cytes and crystal cells but signiﬁcant induction of lamellocytes in
lymph glands from u-shaped trans heterozygous mutant larvae
(Gao et al., 2009) but did not conﬁrm their loss to differentiation,
unlike previously suggested for u-shaped loss-of-function mutants
(Gao et al., 2009). However, the possibility remains that U-shaped
could regulate differentiation of a subset of CZ progenitors, as u-
shaped overexpression using a CZ driver impairs plasmatocyte
formation (Gao et al., 2009).
The similarity of phenotypes induced by u-shaped genetic
manipulation in blood progenitors compared to that of heartless,
pyramus, and thisbe suggested a potential interaction of U-shaped
with Heartless signaling in blood homeostasis. Previous studies
have demonstrated a genetic interaction between u-shaped and
heartless in the context of early mesodermal cell migration,
suggesting that these two genes function in a common genetic
pathway (Fossett et al., 2000), although the mechanism remained
unclear. Our data demonstrate that U-shaped is required either
downstream of or parallel to Heartless signaling to induce differ-
entiation of lymph gland progenitors (Fig. 7P). A link between
receptor tyrosine kinase-ras activity and GATA transcriptional
networks has also been demonstrated in vertebrates. Nearly half
of non-small cell lung cancer (NSCLC) patients contain mutations
in the receptor tyrosine kinase/Ras family, and recent studies
demonstrated that GATA2 transcriptional activity is requisite for
Ras-driven NSCLC cells (Kumar et al., 2012).
We also highlight similar effects of the Drosophila ETS protein
Pointed and the FOG homolog U-shaped as transcriptional effectors
regulating blood progenitor differentiation, and demonstrate that the
differentiation of progenitors induced by activated Pointed requires
U-shaped. Intriguingly, differentiation of the vertebrate myeloid mega-
karyocyte lineage requires cooperativity of ETS and FOG/GATA proteins
M. Dragojlovic-Munther, J.A Martinez-Agosto / Developmental Biology 384 (2013) 313–330 327for transcription of the megakaryocyte-restricted αIIb gene (Wang
et al., 2002). Our study suggests that cooperativity between the
Drosophila FOG and ETS proteins, U-shaped and Pointed, may also
regulate the myeloid-restricted hemocyte differentiation that occurs in
the lymph gland (Fig. 7P), similar to vertebrates. U-shaped has been
shown to bind to at least two Drosophila GATA factors, Serpent and
Pannier (Haenlin et al., 1997; Waltzer et al., 2002), both of which have
roles in blood development (Evans et al., 2003; Minakhina et al., 2011),
yet it remains unclear how U-shaped and these GATA factors function
together in hematopoiesis. Further studies are required to elucidate
U-shaped/GATA transcriptional activity, its targets during Drosophila
hematopoiesis, and the roles of Pointed in this process.Roles of TORC1 and other signaling pathways in
Thisbe/Pyramus-Heartless signaling
Previous studies in Drosophila hematopoiesis have identiﬁed a
number of signals that contribute to lamellocyte differentiation,
including PVR, Toll, ALK and EGFR (Avet-Rochex et al., 2010; Sinenko
et al., 2012; Zettervall et al., 2004), although these studies have been
limited to manipulating gene expression in differentiated hemocytes
(both circulating and in the lymph gland) or within cells of the lymph
gland niche (PSC). Genetic alterations that speciﬁcally induce lamello-
cyte differentiation in the lymph gland prohemocyte population
remain poorly characterized. We have recently demonstrated that
progenitor-speciﬁc TORC1 activation through tsc downregulation is
sufﬁcient to induce signiﬁcant lamellocyte differentiation throughout
the lymph gland (Dragojlovic-Munther and Martinez-Agosto, 2012).
Here we identify that progenitor-speciﬁc overexpression of thisbeWT
and heartlessAct, but not pyramusWT, in the lymph gland also promotes
signiﬁcant lamellocyte differentiation (Fig. 2). However, despite the
shared requirement for Thisbe and Pyramus on Ras signaling through
Pointed in promoting progenitor differentiation and proper CZ forma-
tion (Fig. 5), activation of Ras signaling or PointedP2 gain-of-function
does not induce lamellocyte differentiation (Fig. 3). Given that neither
Ras nor PointedP2 activation in progenitors induces lamellocyte
differentiation, we reasoned that Heartless activation via Thisbe might
branch from the Ras-Pointed signaling cascade and activate TORC1
signaling. Although FGFR signaling (i.e., either through Heartless or
Breathless) has never been shown to signal through TORC1 in
Drosophila, recent studies have suggested synergy between Heartless
and TORC1 signaling during Drosophila post-embryonic gliogenesis
(Avet-Rochex et al., 2012). Our study demonstrates that lamellocyte
differentiation induced by Heartless activation and thisbe overexpres-
sion in blood progenitors is dependent on TORC1 and 4EBP (Figs. 6
and 7P), suggesting that the TORC1 axis may be particularly important
in regulating progenitor-speciﬁc lamellocyte differentiation in the
lymph gland and conﬁrming the ability of FGF signaling to activate
TORC1. In contrast, pyramus overexpression in prohemocytes does
not activate TORC1 signaling, and reducing TORC1 signaling upon
pyramus overexpression does not affect progenitor differentiation
(Fig. 6). Similar ligand-speciﬁc downstream effects have been sug-
gested previously for Heartless signaling (Franzdottir et al., 2009),
demonstrating the context speciﬁcity of its intracellular pathway
components.
Our study has also identiﬁed downregulation of pyramus,
pointed and u-shaped as inducers of lamellocyte formation, while
inhibiting plasmatocyte differentiation, suggesting their role as
negative regulators of lamellocyte differentiation in lymph gland
blood progenitors. This may be a useful mechanism for lineage
restriction under circumstances in which progenitors primarily
differentiate into lamellocytes at the expense of other lineages,
such as upon wasp infection (Krzemien et al., 2010; Rizki and
Rizki, 1984). Further studies are required to elucidate the mechan-
ism by which these pathway components impair lamellocytedifferentiation, which likely involves repression of a signal that
actively promotes lamellocyte differentiation.
Previous studies have identiﬁed roles for the Janus tyrosine
kinase/signal transducers and activators of transcription (JAK/
STAT) and Wingless signaling pathways in the lymph gland MZ
progenitor population (Makki et al., 2010; Sinenko et al., 2009).
Speciﬁcally, the JAK/STAT ligand, Unpaired 3, has been demon-
strated to function in the MZ as part of the immune response, such
that wasp infestation induces reduced levels of unpaired 3 tran-
scripts in the lymph gland, which in turn decreases JAK/STAT
signaling levels and thus transcription of the target gene, dome
(Makki et al., 2010). Latran, a short, non-signaling, cytokine dome-
cognate receptor, is expressed in the MZ, and further contributes
to the decreased JAK/STAT signaling which follows wasp infesta-
tion and is required for the massive lamellocyte differentiation
that occurs in response to parasitization (Makki et al., 2010). Akin
to what is seen with Latran, we hypothesize that Thisbe-mediated
Heartless signaling may cooperate with STAT under immune
challenge, particularly in lamellocyte formation. As we discuss
below, Thisbe could be a potential mediator of the lamellocyte
response upon wasp parasitization. Although regulated JAK/STAT
signaling in the MZ is required as part of the lymph gland immune
response (Makki et al., 2010), recent studies have suggested that
the role for STAT in lymph gland prohemocyte maintenance is
actually mediated via non-autonomous signaling in the adjacent
CZ (Mondal et al., 2011). Therefore, the robust effects on progenitor
differentiation or maintenance that we observe upon prohemocyte-
speciﬁc gain- or loss-of-function of Heartless signaling, respectively,
likely occurs independent of JAK/STAT signaling. However, we
cannot rule out that, as previously shown (Gao et al., 2009), JAK/
STAT signaling could regulate u-shaped expression in the lymph
gland and in turn contribute to Heartless-induced progenitor
differentiation. We do, however, speculate that Wingless signaling,
a prohemocyte maintenance signal autonomously required in the
MZ (Sinenko et al., 2009), may suppress the pro-differentiation
effects mediated by Thisbe and Pyramus, given the similarities
between Wingless gain-of-function and reduced Heartless-Ras-
Pointed signaling in the progenitor population (Figs. 2 and 3 and
Sinenko et al., 2009).
Thisbe/Pyramus-Heartless signaling is modulated by Trol in the
extracellular matrix
Given the robust effects on lymph gland differentiation that
occur upon forcibly overexpressing the Heartless ligands, thisbe
and pyramus, in dome+ hemocyte progenitors, it was surprising
that thisbe and pyramus are both highly expressed in the undiffer-
entiated cells of the MZ (Figs. 1 and S1). Furthermore, the impaired
CZ formation upon progenitor-speciﬁc thisbe or pyramus down-
regulation suggested to us that the FGF pathway is required in
dome+ cells to restrict the progenitor state. Such highly regulated
Heartless signaling would thus require a mechanism by which to
regulate Heartless signaling in progenitors, in order to prevent
precocious differentiation. One candidate modulator of Heartless
signaling that we hypothesized could be functioning in the lymph
gland is the Drosophila Perlecan homolog, Trol, as heparan sulfate
proteoglycans (HSPGs) are known to modulate the signaling of a
number of secreted ligands. Amongst these, HSPGs have the ability
to sequester FGF ligands, regulating their movement and diffusi-
bility through the extracellular matrix (Turner and Grose, 2010). In
the lymph gland, a dense trol-positive extracellular matrix reticu-
lum surrounds MZ progenitors, whereas in the CZ much of this
extracellular matrix has disappeared (Fig. 7J). Reduced expression
of trol in the MZ induces precocious prohemocyte differentiation
at early and late lymph gland stages, and this effect is rescued by
blocking Heartless signaling. Likewise, increased differentiation is
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Our ﬁndings are consistent with previous studies that have shown
gain-of-function phenotypes in fgf mutants with reduced binding
afﬁnity to heparan sulfate (Harada et al., 2009; Makarenkova et al.,
2009), and suggest that Trol contributes to maintain a reservoir of
sequestered Heartless ligands in the lymph gland (Fig. 7P), which
become available upon disruption of trol expression.
The role of sequestration of FGF ligands in hematopoiesis is
likely multi-faceted. First, the highly regulated release of seques-
tered Thisbe and Pyramus ligands, perhaps via expression of
heparanases, may be responsible for regulating progenitor differ-
entiation and for patterning CZ formation during development.
Further studies are required to investigate which signals are
responsible for mediating such a stereotypical release of Heartless
ligands during lymph gland development. Additionally, the con-
tinued presence of thisbe and pyramus in medial lymph gland
regions by wandering third instar stages also suggests that Heart-
less ligands may become available following the onset of meta-
morphosis, contributing to the rapid differentiation of lymph
gland progenitors that occurs before their release into circulation
upon pupation (Grigorian et al., 2011b). Consistent with this
ﬁnding, the strong trol expression observed in the MZ late in
larval development is reduced at the onset of pupation, when
metamorphosis begins (Grigorian et al., 2011b). Finally, a reservoir
of immobilized Heartless ligands, present in lymph gland progeni-
tors throughout development, may also be utilized to induce the
rapid differentiation of hemocytes observed in response to larval
infection or stress conditions (Krzemien et al., 2010; Lemaitre and
Hoffmann, 2007; Shim et al., 2012). Intriguingly, parasitoid infec-
tion of Drosophila larvae induces massive lamellocyte differentia-
tion in the lymph gland (Lanot et al., 2001; Sorrentino et al., 2002),
and genome-wide expression analyses identiﬁed a number of
proteases to be upregulated in response to parasitoid infection in
Drosophila (Wertheim et al., 2005). It remains to be determined
whether a release of sequestered Thisbe ligand follows the upregula-
tion of protease expression and contributes to the increased lamel-
locyte differentiation in the lymph gland that occurs upon wasp
parasitization.
Previous studies in the lymph gland have revealed signaling
networks that actively maintain progenitors, uncovering niche-,
progenitor-, and differentiated hemocyte-derived maintenance
signals that serve this function (Mandal et al., 2007; Mondal
et al., 2011; Sinenko et al., 2009). Our study highlights the role
of a Heartless-Ras-Pointed signaling pathway that is both required
and sufﬁcient for progenitor differentiation and CZ formation. We
uncover a novel mechanism of progenitor maintenance in the
lymph gland, wherein sequestration of a differentiation signal
developmentally also supports progenitor maintenance and pre-
vents their precocious differentiation. This mechanism of ligand
sequestration may be relevant in vertebrate hematopoiesis,
wherein FGFs have been implicated in myeloid-lineage restricted
progenitors and cell types (Allouche and Bikfalvi, 1995; Berardi
et al., 1995; Moroni et al., 2002). Furthermore, signaling through
ETS, FOG and the target of rapamycin pathway may be important
in conditions of dysregulated FGF signaling, such as acute myeloid
leukemias (Bieker et al., 2003; Karajannis et al., 2006).Acknowledgments
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